Genetics Suggest New Vitiligo Treatment Path
A new study by Kang et al. has uncovered a surprising potential benefit of PCSK9 inhibitors—drugs typically prescribed to lower cholesterol. Through Mendelian randomization (MR), researchers found that people with genetic variants mimicking the effects of PCSK9-inhibiting drugs had a lower risk of developing vitiligo. This unexpected link offers fresh insight into vitiligo’s underlying biology … Read more